Walk into any cannabis dispensary in Thailand and you will encounter two abbreviations on virtually every product label: THC and CBD. They appear together, they are both cannabinoids, they both come from the same plant — and yet they produce almost entirely opposite effects in the human body. Understanding the difference between them is the single most useful piece of cannabis knowledge a first-time consumer can have.
This guide explains what THC and CBD are, how they work at a receptor level, what they actually feel like, and how to think about the ratio between them when choosing a product.
What Are Cannabinoids?
THC and CBD are both cannabinoids — a class of chemical compounds that interact with the body's endocannabinoid system (ECS). The ECS is a cell-signalling network distributed throughout the body, involved in regulating pain, inflammation, mood, sleep, appetite, stress response, and memory. It consists of endocannabinoid receptors (primarily CB1 and CB2), endogenous cannabinoids the body produces naturally (anandamide and 2-AG), and the enzymes that synthesise and break them down.
Plant-derived cannabinoids like THC and CBD are called phytocannabinoids. They interact with the ECS — but in very different ways, which explains why their effects are so different despite sharing a common chemical family.
Cannabis plants produce over 100 identified phytocannabinoids. THC (tetrahydrocannabinol) and CBD (cannabidiol) are the two most abundant and most studied. They are produced in the same part of the plant — the trichomes — and both begin their biosynthesis from the same precursor molecule, cannabigerolic acid (CBGA). From there, different enzymes divert the molecule toward either THCA (which becomes THC) or CBDA (which becomes CBD) when the plant material is heated or aged.
How THC Works: The Psychoactive Pathway
THC is the primary psychoactive compound in cannabis. Its effects are produced by direct binding to CB1 receptors in the central nervous system — the brain and spinal cord. CB1 receptors are densely expressed in the regions that THC affects most strongly: the prefrontal cortex (executive function, decision-making), the hippocampus (memory), the basal ganglia (movement and reward), the cerebellum (coordination), and the limbic system (emotions).
THC is a partial agonist at CB1 receptors — it activates them, but not to the maximum possible extent. This activation produces the constellation of effects cannabis is famous for: euphoria, altered sensory perception, changes in time perception, relaxation, increased appetite, and, at higher doses, short-term memory impairment, anxiety, and paranoia.
The intensity of these effects is the primary variable controlled by THC percentage. A product with 25% THC will produce significantly more pronounced psychoactivity than one with 12% THC. For new consumers or those sensitive to psychoactive effects, THC percentage is the most important single number on the label.
THC also binds CB2 receptors, which are expressed primarily in immune tissue, to a lesser degree. This contributes to some of cannabis's anti-inflammatory effects, though less directly than β-caryophyllene (which binds CB2 selectively) or CBD.
How CBD Works: The Modulating Compound
CBD is not psychoactive — it does not produce a high, alter sensory perception, or impair cognition in the way THC does. This is the single most important practical distinction, and it is the source of most consumer confusion.
CBD's mechanism is considerably more complex than THC's and involves multiple receptor systems rather than a single primary target:
- CB1 receptor antagonism: Rather than activating CB1 receptors, CBD acts as a negative allosteric modulator — it changes the shape of the CB1 receptor in a way that makes it less responsive to activation. This is the primary reason CBD reduces THC's psychoactive intensity: when both are present, CBD physically modulates the receptor that THC is trying to activate, softening the high.
- CB2 receptor partial agonism: CBD activates CB2 receptors at relatively low potency, contributing to its anti-inflammatory effects.
- 5-HT1A receptor agonism: CBD activates serotonin receptors, specifically the 5-HT1A subtype. This is thought to underlie its anxiolytic and antidepressant properties — the same receptor targeted by buspirone and partially by SSRIs.
- TRPV1 (vanilloid receptor) activation: CBD activates TRPV1 receptors, which are involved in pain signalling and inflammation. This contributes to its analgesic effects independently of the endocannabinoid pathway.
- Endocannabinoid reuptake inhibition: CBD inhibits the reuptake of anandamide, the body's natural "bliss" endocannabinoid, allowing it to remain active in the synapse for longer. This enhances endocannabinoid tone without directly activating cannabinoid receptors.
The practical result of this multi-receptor profile is that CBD produces a range of effects — relaxation, anxiety reduction, pain relief, reduced inflammation, improved sleep in some users — without psychoactivity. It is calming without being intoxicating, and it actively blunts the most intense aspects of a THC experience.
What They Actually Feel Like
THC alone (high-THC, low-CBD product): Euphoria, sensory enhancement, time distortion, increased appetite, deep relaxation or energisation depending on terpene profile, and at high doses — anxiety, racing thoughts, paranoia, and memory impairment. The intensity scales with THC percentage and individual sensitivity. New consumers and those prone to anxiety should start very low and go slow.
CBD alone (CBD-only product, no THC): Subtle calming and relaxation without any intoxication. Mild anxiety reduction. A gentle sense of ease without any cognitive alteration. Many people report noticing very little from CBD alone, especially at lower doses — it is not a "drug" in the experiential sense that THC is. Its effects are cumulative and often more apparent with consistent use than from a single dose.
A balanced CBD:THC product (e.g. 1:1 ratio): This is where the combination becomes interesting. CBD's CB1 receptor modulation reduces the ceiling of THC's psychoactivity — you still feel the cannabis, but the anxiety, paranoia, and cognitive impairment are significantly attenuated. The experience is often described as warmer and more grounded than high-THC products. Many experienced consumers prefer balanced ratios for everyday use precisely for this reason.
The THC:CBD Ratio Explained
Cannabis products are increasingly labelled with THC:CBD ratios, which is a more useful framing than either number in isolation. Here is how to read them:
- High THC, low CBD (e.g. 25% THC, <1% CBD): Most commercial cannabis flower in Thailand falls into this category. Maximum psychoactivity, minimal CBD modulation. Appropriate for experienced consumers who know their tolerance. New consumers or anxiety-prone individuals should approach with caution.
- Moderate THC with CBD present (e.g. 15% THC, 5% CBD — a 3:1 ratio): The CBD meaningfully reduces anxiety and cognitive fog while preserving significant psychoactivity. A good starting point for new consumers who want an actual cannabis experience, not just CBD's subtlety.
- Balanced 1:1 (e.g. 10% THC, 10% CBD): A genuinely different experience from either compound alone. Relaxing, warm, with noticeable but manageable psychoactivity. Often recommended for consumers using cannabis for pain, anxiety, or sleep where a full intoxicating experience is not desired.
- High CBD, low THC (e.g. 1% THC, 15% CBD): Minimal to no psychoactivity. Mainly used for therapeutic purposes — pain management, anxiety, inflammation, sleep — where intoxication is specifically unwanted. These products are widely available in Thailand in both flower and extract form.
- CBD-only (<0.3% THC): No psychoactivity. Available widely in health stores across Thailand as oils, topicals, and supplements, separate from dispensaries. Legal without restriction.
Medical and Therapeutic Applications
The research profiles of THC and CBD point to different therapeutic strengths:
THC's established therapeutic applications include: pain management (particularly neuropathic pain, via CB1 receptor activity); nausea and vomiting reduction (the basis of pharmaceutical THC drugs like dronabinol); appetite stimulation in wasting conditions; muscle spasticity reduction in multiple sclerosis; and sleep induction. THC is also documented as an anxiolytic at low doses — though at high doses it is one of the most reliably anxiety-inducing compounds in the pharmacopeia, making dose precision critical.
CBD's established therapeutic applications include: anticonvulsant activity (Epidiolex, a pharmaceutical CBD product, is approved for treatment-resistant epilepsy); anxiety disorder management; anti-inflammatory effects; neuroprotection; and adjunctive pain management. CBD is generally safer at high doses than THC — it has been administered at 1,500mg/day in clinical trials without significant adverse effects — and it does not produce dependence.
For most therapeutic applications, the combination of both cannabinoids at an appropriate ratio tends to outperform either in isolation. The synergy between THC and CBD — where CBD moderates THC's adverse effects while both contribute to therapeutic endpoints — is the pharmacological basis of whole-plant cannabis preparations and balanced-ratio products.
CBD and THC in Thai Law
Thailand's cannabis regulations treat THC and CBD very differently:
CBD is widely legal in Thailand with no meaningful restriction. CBD products — oils, supplements, topicals, food products — are sold in pharmacies, health stores, and convenience stores across the country without a prescription or special dispensary licence. There is no age requirement for CBD-only products.
THC-containing cannabis (flower, extracts, concentrates) must be purchased from a licensed dispensary. Buyers must be 20 years of age or older with valid ID. Public consumption is prohibited. Export is strictly illegal.
Products with very high THC extract concentrations (particularly concentrates above certain thresholds) occupy a regulatory grey area — check with the dispensary for the current legal status of specific product types.
Practical Advice for Thailand Visitors
If you are new to cannabis or haven't consumed in some time, a CBD-present product is almost always the better starting point, regardless of your previous experience. Thai flower skews high in THC — 20–28% is common — and the potency surprises many visitors who underestimate it relative to what they've encountered elsewhere.
A few concrete suggestions:
- If you are completely new: start with a balanced 1:1 or high-CBD product. Keep the THC dose low regardless of what you read about the strain.
- If you are experienced but haven't consumed recently: treat yourself as intermediate. Start with a mid-THC product (15–20%) with some CBD present.
- If you have a specific therapeutic goal (pain, sleep, anxiety) without wanting intoxication: high-CBD, low-THC products are the cleaner choice — ask dispensary staff specifically for these rather than standard flower.
- If you are combining with alcohol: be cautious. The combination significantly amplifies both substances and is the most common source of uncomfortable experiences for tourists.
Finding the Right Product in Thailand
Dispensaries listed on Dispensary Thailand include menu information where operators have provided it. Look for dispensaries that list both THC and CBD percentages for their flower — this is the minimum information you need to make an informed choice. Dispensaries that also provide terpene data (see our terpene guide) are the most sophisticated operators and will give you the most useful guidance on what to expect.
When in doubt, ask the dispensary staff directly: "What do you have that has both THC and CBD?" A quality dispensary will have options and will be able to explain the difference between them. If they look confused by the question, that tells you something too.